Live Tracker
Biotech M&A Tracker 2026
Every control transaction in 2026 — target, acquirer, deal value, premium-to-unaffected, and investor-grade rationale.
71 deals. ~$189.6B tracked.
Last updated 26 August 2026
Daily Intelligence for Biotech Investors
The deal tapeserious biotech investors actually read
Top news, M&A, BD&L, IPOs, and VC financings — distilled to a 5-minute read every market morning. No hype. No filler. Just the signal.
Trusted by 2,000+ biotech execs, VCs, BD leads, public market investors - free
2,000+
Subscribers
5×
Issues per week
16+
Research reports
~$189.6B
M&A tracked YTD
Research Hub
Live trackers & research
Live Trackers
Research
About BioBucks
BioBucks is a daily newsletter for biotech and biopharma investors — covering M&A, BD&L deals, IPOs, venture rounds, and catalyst-driven market moves, with the framing that institutional dealmakers actually care about.
Every edition is written to be read in under 5 minutes, with the why it matters front and centre. No press release regurgitation. No noise.
Alongside the daily tape, the Research Hub provides live trackers and standalone reports that serve as reference tools for the community.
Who reads BioBucks